Over 60% of SERBP1-associated proteins detected in Tau aggregates get PARylated and/or bind PAR (Gibson et al., 2016; Martello et al., 2016; Dasovich et al., 2021) and increased SERBP1-PARP1 interaction was observed in AD brains. Here, MAPT is linked to Alzheimer disease.